BioAge Labs, Inc.
BIOA
$4.38
$0.153.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.16M | 16.54M | 15.16M | 14.54M | 14.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.19M | 66.43M | 51.57M | 49.71M | 48.40M |
| Operating Income | -78.19M | -66.43M | -51.57M | -49.71M | -48.40M |
| Income Before Tax | -71.11M | -70.94M | -62.16M | -65.76M | -63.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.11 | -70.94 | -62.16 | -65.76 | -63.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.11M | -70.94M | -62.16M | -65.76M | -63.85M |
| EBIT | -78.19M | -66.43M | -51.57M | -49.71M | -48.40M |
| EBITDA | -78.03M | -66.27M | -51.39M | -49.55M | -48.24M |
| EPS Basic | -22.99 | -34.93 | -36.97 | -39.31 | -38.17 |
| Normalized Basic EPS | -14.27 | -17.97 | -19.24 | -20.70 | -20.09 |
| EPS Diluted | -22.99 | -34.93 | -36.97 | -39.31 | -38.17 |
| Normalized Diluted EPS | -14.27 | -17.97 | -19.24 | -20.70 | -20.09 |
| Average Basic Shares Outstanding | 42.89M | 8.55M | 6.73M | 6.69M | 6.69M |
| Average Diluted Shares Outstanding | 42.89M | 8.55M | 6.73M | 6.69M | 6.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |